The preservative-free corticosteroid is approved by the FDA for vitrectomy visualization, as well as the treatment of recalcitrant ocular inflammation.
Biomea Fusion announced a clinical hold by the U.S. FDA on its diabetes drug trial due to potential toxic liver disease, causing a 60% drop in its shares.
Reuters
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.
Health care professionals welcome the FTC's new rule banning noncompete agreements but are concerned it may not protect those in nonprofit health care settings, potentially impacting most of the nation's medical professionals.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.